StonvexLoading…
StonvexStonvexStonvexCore line items from AMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $523.53M | $2.12B | $1.60B | $1.08B |
Operating Income | $-10.43M | $-61.37M | $-40.04M | $-37.52M |
Net Income | $-11.03M | $-61.69M | $-44.42M | $-4.95M |
EPS (Diluted) | $-0.86 | $-4.75 | $-3.41 | $-2.98 |
Total Assets | $2.28B | $2.28B | $2.35B | $2.37B |
Total Liabilities | $765.48M | $735.13M | $753.17M | $759.40M |
Cash & Equivalents | $317.23M | $365.97M | $408.52M | $449.03M |
Free Cash Flow OCF − CapEx | $-11.62M | $17.77M | $27.76M | $2.32M |
Shares Outstanding | 12.75M | 12.81M | 12.92M | 13.05M |